Tema Neuroscience and Mental Health ETF (MNTL) Holdings $25.40 -0.04 (-0.14%) As of 02/21/2025 03:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Top 50 MNTL HoldingsRankCompanyCurrent PriceWeightShares Held1VRTXVertex Pharmaceuticals$484.24+0.8%9.60%2,2982REGNRegeneron Pharmaceuticals$700.33+0.6%6.60%1,0843ARGXargenx$644.48-0.5%5.24%8904ALNYAlnylam Pharmaceuticals$250.59-0.2%4.74%1,9825TEVATeva Pharmaceutical Industries$16.75-1.5%4.34%28,8616LLYEli Lilly and Company$874.12+0.1%4.31%5477NBIXNeurocrine Biosciences$120.69+3.9%3.28%3,1088MDTMedtronic$89.95+2.3%3.23%3,8799BIIBBiogen$140.64+2.6%3.13%2,50110UCB SAN/A3.12%1,764 Get the Latest News and Ratings for MNTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. 11CRNXCrinetics Pharmaceuticals$37.48+1.7%2.85%8,94112SYKStryker$382.59-1.0%2.80%79813AXSMAxsome Therapeutics$137.75+6.7%2.77%2,32714ITCIIntra-Cellular Therapies$128.60+0.0%2.43%2,09815CPRXCatalyst Pharmaceuticals$21.63-1.9%2.39%11,35216DNLIDenali Therapeutics$20.75-3.9%2.29%11,89417IONSIonis Pharmaceuticals$32.33-1.1%2.28%8,31818XENEXenon Pharmaceuticals$39.73+0.9%2.17%6,11119JAZZJazz Pharmaceuticals$136.01-0.5%2.07%1,67220ALKSAlkermes$35.33-0.5%1.93%5,94021SRPTSarepta Therapeutics$106.28-2.0%1.92%1,94322ACADACADIA Pharmaceuticals$19.95-1.7%1.89%10,59623DAWNDay One Biopharmaceuticals$12.43+1.6%1.74%15,82024DXCMDexCom$88.78-0.6%1.69%2,23125SRRKScholar Rock$37.70-3.7%1.64%4,83626RNAAvidity Biosciences$31.12-4.3%1.61%5,39227PENPenumbra$292.52-3.5%1.52%61728BHVNBiohaven$36.90-7.2%1.45%3,83129OPCHOption Care Health$32.00-1.2%1.43%4,97530PTCTPTC Therapeutics$50.69+0.6%1.40%3,12431Siemens Healthineers AGN/A1.37%2,49532First American Treasury Obligations FundN/A1.11%123,37233IMVTImmunovant$21.26+4.0%1.05%5,86634Sysmex CorporationN/A1.00%6,10835ACHCAcadia Healthcare$39.65-2.5%0.98%2,59636NTLAIntellia Therapeutics$12.17-0.7%0.96%11,04437PRAXPraxis Precision Medicines$74.49-6.3%0.83%1,05538PRTAProthena$15.56+2.0%0.80%6,35139Orion OyjN/A0.71%1,44040TALKTalkspace$3.01-8.5%0.69%18,206Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.You MUST act before March 17th.41DYNDyne Therapeutics$14.01+0.1%0.60%4,71742VYGRVoyager Therapeutics$4.22-0.9%0.59%14,96043Eisai Co., Ltd.N/A0.53%2,03644ARVNArvinas$17.77-3.3%0.33%2,07445SLDBSolid Biosciences$5.78-3.7%0.31%8,64946RAPPRapport Therapeutics$12.68-2.5%0.21%1,49947EURON/A0.06%6,57148JAPANESE YENN/A0.03%425,87449US DOLLARSN/A0.00%8250DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A-0.02%26,115,356 Geographic ExposureUnited States80.9%Ireland7.2%Belgium3.0%Canada2.2%Japan1.5%Virgin Islands, British1.4%Germany1.3%Finland0.7%Currency ExposureUSD93.4%EUR5.0%JPY1.5%Sector ExposureHealth Care89.1%Industry ExposureBiotechnology75.2%Health Care Equipment & Supplies10.9%Pharmaceuticals2.0%Health Care Providers & Services0.9%SubIndustry ExposureBiotechnology67.0%Health Care Equipment9.9%Pharmaceuticals4.7%Life Sciences Tools & Services1.0%Health Care Facilities0.9%Coupon Exposure4-61.1%Maturity Exposure15-201.1% Related Companies and Tools Related Companies FIVY Holdings IBOT Holdings AQWA Holdings EQRR Holdings DECO Holdings SPCX Holdings NIKL Holdings KROP Holdings GXTG Holdings TMET Holdings This page (NASDAQ:MNTL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
